DNA Stock Analysis: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$8.73
-0.60 (-6.43%)
▼
5d:
+0.23%
30d:
-11.91%
90d:
+30.49%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called DNA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DNA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: DNA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $8.73, which is considered fair relative to its 30-day fair value range of $7.81 to $9.50.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $7.25, while resistance sits at $9.75. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: DNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $7.25, while resistance sits at $9.75. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: DNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.81 -
$9.50
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BEARISH: Trading above Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$7.81 -
$9.50
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.25
Resistance Level
$9.75
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.91
Wall Street Target
$8.50
(-8.9%)
Revenue Growth (YoY)
-49.1%
Profit Margin
-201.0%
Share & Embed Analysis
Last updated: June 03, 2026 4:40 PM ET
Data refreshes hourly during market hours. Next update: 5:40 PM
Data refreshes hourly during market hours. Next update: 5:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
324 shares
2026-04-17
Steven P Coen
SELL
33171 shares
2026-04-13
Barry Canton
SELL
124727 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
